Development and characterization of α-Mangostin-loaded polymeric nanoparticles for intranasal brain delivery: pharmacokinetic evaluation and preliminary in-vitro neuroprotective assessment

α-Mangostin (αM) belongs to a bioactive xanthone derivative, having antioxidant​ and potential neuroprotective properties. However, its therapeutic applications are restricted due to limited aqueous solubility and limited penetration across the blood-brain barrier (BBB) of the brain. The present study aimed to develop αM-loaded polymeric nanoparticles for a intranasal delivery and improved brain availability. αM was initially selected through a multiscale in-silico studies. The optimized αM-PNPs (polylactide-co-glycolide as PLGA nanoparticles) were characterized using the physicochemical, in-vitro , and ex - vivo evaluations, followed by long-term stability studies. I n vivo pharmacokinetics were conducted in rats and a preliminary neuroprotective activity was evaluated in OGD/R-induced BV-2 cells. The in-silico analysis showed a favorable docking score (-9.980 kcal/mol) for αM and formed a stable complex with the PPAR-γ receptor throughout a 200ns MD simulation, supporting its predicted interaction with PPAR-γ. The optimized αM-PNPs exhibited a mean particle size of 232.63 ± 5.03 nm, a zeta potential of -20.9 ± 2.27 mV, an encapsulation efficiency (%EE) of 84.7 ± 3.57%, a drug loading (%DL) of 14.5 ± 1.08%, and a polydispersity index (PDI) of 0.191 ± 0.024. The αM-PNPs exhibited a biphasic drug release profile, with approximately 88% cumulative drug release over 12 h. However, based on the reported regression coefficients​, the release profile was best fitted to first-order and Hixson-Crowell models (r² = 0.9976). The steady state permeation flux value ( J ss ) of αM-PNPs (573.98 ± 17.1 µg/h.cm 2 ) was relatively higher than αM-SUS (316.8 ± 10.6 µg/h.cm 2 ), demonstrating an intense modulation of the BBB for improved penetration into the brain. The optimized αM-PNPs demonstrated a satisfactory long-term stability under the controlled storage conditions. αM-PNPs showed enhanced brain drug availability and improved in vitro cytoprotective activity (BV-2) as compared to αM-SUS. Overall, the developed intranasal αM-PNPs represent a promising non-invasive strategy for enhancing nose-to-brain delivery of αM.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-19
DOI
https://doi.org/10.1038/s41598-026-80036-9
Primary Topic
Advanced Drug Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Development and characterization of α-Mangostin-loaded polymeric nanoparticles for intranasal brain delivery: pharmacokinetic evaluation and preliminary in-vitro neuroprotective assessment

Tahir Khuroo, Zahid Rafiq, Yogeeta O. Agrawal, Aarti V. Belgamwar et al.
Scientific Reports
Advanced Drug Delivery Systems
article

Development and characterization of α-Mangostin-loaded polymeric nanoparticles for intranasal brain delivery: pharmacokinetic evaluation and preliminary in-vitro neuroprotective assessment

Tahir Khuroo, Zahid Rafiq, Yogeeta O. Agrawal, Aarti V. Belgamwar, Afzal Hussain, Mohammad A. Altamimi, Mohd Usman Mohd Siddique, Azim Ansari, Chaitali Pardeshi, Prafull Shinde, Mrugendra Potdar
article en

Abstract

α-Mangostin (αM) belongs to a bioactive xanthone derivative, having antioxidant​ and potential neuroprotective properties. However, its therapeutic applications are restricted due to limited aqueous solubility and limited penetration across the blood-brain barrier (BBB) of the brain. The present study aimed to develop αM-loaded polymeric nanoparticles for a intranasal delivery and improved brain availability. αM was initially selected through a multiscale in-silico studies. The optimized αM-PNPs (polylactide-co-glycolide as PLGA nanoparticles) were characterized using the physicochemical, in-vitro , and ex - vivo evaluations, followed by long-term stability studies. I n vivo pharmacokinetics were conducted in rats and a preliminary neuroprotective activity was evaluated in OGD/R-induced BV-2 cells. The in-silico analysis showed a favorable docking score (-9.980 kcal/mol) for αM and formed a stable complex with the PPAR-γ receptor throughout a 200ns MD simulation, supporting its predicted interaction with PPAR-γ. The optimized αM-PNPs exhibited a mean particle size of 232.63 ± 5.03 nm, a zeta potential of -20.9 ± 2.27 mV, an encapsulation efficiency (%EE) of 84.7 ± 3.57%, a drug loading (%DL) of 14.5 ± 1.08%, and a polydispersity index (PDI) of 0.191 ± 0.024. The αM-PNPs exhibited a biphasic drug release profile, with approximately 88% cumulative drug release over 12 h. However, based on the reported regression coefficients​, the release profile was best fitted to first-order and Hixson-Crowell models (r² = 0.9976). The steady state permeation flux value ( J ss ) of αM-PNPs (573.98 ± 17.1 µg/h.cm 2 ) was relatively higher than αM-SUS (316.8 ± 10.6 µg/h.cm 2 ), demonstrating an intense modulation of the BBB for improved penetration into the brain. The optimized αM-PNPs demonstrated a satisfactory long-term stability under the controlled storage conditions. αM-PNPs showed enhanced brain drug availability and improved in vitro cytoprotective activity (BV-2) as compared to αM-SUS. Overall, the developed intranasal αM-PNPs represent a promising non-invasive strategy for enhancing nose-to-brain delivery of αM.

Scientific Reports
Texas A&M Health Science Center (US), The University of Texas at El Paso (US), Narsee Monjee Institute of Management Studies (IN), King Saud University (SA), Shri Vile Parle Kelavani Mandal (IN), Texas A&M University (US)
Advanced Drug Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon